Gene Therapy Engineer - Vector Design

17 February 2020

Get in touch!

Interested?

For more information please contact Prof. Dr. Els Henckaerts (els.henckaerts@kuleuven.be) or Dr Veronick Benoy (veronick.benoy@kuleuven.be).

You can apply for this job no later than March 16, 2020 via the online application tool

KU Leuven seeks to foster an environment where all talents can flourish, regardless of gender, age, cultural background, nationality or impairments. If you have any questions relating to accessibility or support, please contact us at diversiteit.HR@kuleuven.be.

Apply before 16 March 2020

The Laboratory of Viral Cell Biology and Therapeutics (LVCBT) at KU Leuven is recruiting a highly motivated and skilled researcher to fulfill the role of Gene Therapy Engineer - Vector Design.

This vacancy is in the context of the establishment of a clinical program geared towards the treatment of neurodegenerative diseases using AAV vectors. This program will be performed in close collaboration with a biotech company and provides a unique opportunity to contribute to the development of an exciting therapeutic modality.

The position is available immediately

Responsibilities
  • You are part of a drug development team in a stimulating setting
  • You are responsible for the design/optimization of viral vectors
  • You are responsible for verifying vector performance using a number of assessment methodologies
  • You are responsible for reporting on the development process
  • You discuss progress of the research with the supervisor and with the industrial stakeholders
Profile
  • You have a M.Sc. or Ph.D. in biomedical sciences, bioscience engineering or equivalent, with minimum 3 years of experience
  • Strong hands-on expertise in molecular biology (vector design, DNA cloning techniques, shRNA/siRNA technology, CRISR Cas9,…)
  • You pay attention to details and produce high-quality work
  • You are a team player with strong communication skills
  • You are fluent in English
Offer
  • We offer a full-time appointment for one year, with the option to extend
  • A stimulating work environment driven by the ambition to deliver new therapeutics to patients in collaboration with industry
  • Superb career development opportunities with exposure to R&D in an exciting new therapeutic modality; possibility to interact with international collaborators